You are here

Hedge funds stung by mega-deal collapse

But no-go on Pfizer-Allergan merger mitigated by mix of of earlier optimism and reluctance on taking super-size positions

BT_20160408_DNDEAL_2211560.jpg
The US$160 billion merger is pulled after the US Treasury drafted new rules to deter companies from moving their headquarters to countries with a more favourable tax regime.

BT_20160408_DNDEAL_2211560.jpg
The US$160 billion merger is pulled after the US Treasury drafted new rules to deter companies from moving their headquarters to countries with a more favourable tax regime.

London

HEDGE funds which bet on mergers and acquisitions were hurt by the collapse of a US$160 billion tie-up between pharmaceutical companies Pfizer and Allergan - although the effects could have been even worse.

The deal was pulled after the US Treasury drafted new rules to deter

sentifi.com

Market voices on:

Powered by GET.comGetCom